Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:AEMDNASDAQ:LYRANASDAQ:STRROTCMKTS:UAHC On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeAEMDAethlon Medical$0.36-3.9%$0.38$0.24▼$1.06$5.77M1.932.30 million shs105,123 shsLYRALyra Therapeutics$20.25+310.8%$5.20$3.81▼$36.73$26.83M0.04121,568 shs26.55 million shsSTRRStar Equity$2.63+10.3%$2.14$1.72▼$5.35$8.42M0.8718,469 shs61,217 shsUAHCUnited American Healthcare$0.01$0.01$0.01▼$0.11$1.65M-1.5923,263 shs60 shs12 Stocks Corporate Insiders are AbandoningIf a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know? MarketBeat just compiled its list of the twelve stocks that corporate insiders are abandoning. Complete the form below to see which companies made the list.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceAEMDAethlon Medical0.00%-9.47%-9.95%-19.94%-17.57%LYRALyra Therapeutics0.00%+1.96%-13.57%-51.85%-71.46%STRRStar Equity0.00%+0.99%-9.42%-5.17%-53.03%UAHCUnited American Healthcare0.00%0.00%+2.17%-11.88%-43.82%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationAEMDAethlon Medical2.915 of 5 stars3.55.00.00.02.20.01.3LYRALyra Therapeutics2.7779 of 5 stars3.24.00.00.03.31.70.6STRRStar Equity2.4701 of 5 stars3.53.00.00.00.91.71.3UAHCUnited American HealthcareN/AN/AN/AN/AN/AN/AN/AN/ACompare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceAEMDAethlon Medical 3.00Buy$7.001,828.37% UpsideLYRALyra Therapeutics 2.33Hold$100.00225.41% UpsideSTRRStar Equity 3.00Buy$5.0092.31% UpsideUAHCUnited American Healthcare 0.00N/AN/AN/ACurrent Analyst Ratings BreakdownLatest UAHC, STRR, AEMD, and LYRA Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails5/15/2025STRRStar EquityMaxim GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetBuy ➝ Buy$8.00 ➝ $5.003/14/2025LYRALyra TherapeuticsHC WainwrightSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingNeutral ➝ Neutral$100.00 ➝ $100.003/10/2025AEMDAethlon MedicalHC WainwrightSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Buy$7.00 ➝ $7.00(Data available from 6/2/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookAEMDAethlon Medical$570K10.23N/AN/A$2.19 per share0.17LYRALyra Therapeutics$1.19M34.36N/AN/A$1.56 per share19.70STRRStar Equity$57.17M0.15$0.43 per share6.11$14.63 per share0.18UAHCUnited American HealthcareN/AN/AN/AN/AN/AN/ACompare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateAEMDAethlon Medical-$12.21M-$1.58N/AN/AN/AN/A-153.96%-109.13%6/26/2025 (Estimated)LYRALyra Therapeutics-$62.68M-$60.50N/AN/AN/A-6,635.76%-125.07%-59.74%8/12/2025 (Estimated)STRRStar Equity$25.13M-$3.43N/AN/AN/A-12.41%-8.72%-4.62%8/12/2025 (Estimated)UAHCUnited American Healthcare$720KN/A0.00∞N/AN/AN/AN/AN/ALatest UAHC, STRR, AEMD, and LYRA EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails6/26/2025Q4 2025AEMDAethlon Medical-$0.13N/AN/AN/AN/AN/A5/14/2025Q1 2025STRRStar Equity-$0.25-$0.52-$0.27-$0.37$16.35 million$12.92 million5/6/2025Q1 2025LYRALyra Therapeutics-$7.50-$6.00+$1.50-$0.13$0.16 million$0.18 million3/20/2025Q4 2024STRRStar Equity-$0.17$0.15+$0.32-$0.94$14.00 million$17.10 million3/13/2025Q4 2024LYRALyra Therapeutics-$6.00-$8.00-$2.00-$0.16$0.21 million$0.21 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthAEMDAethlon MedicalN/AN/AN/AN/AN/ALYRALyra TherapeuticsN/AN/AN/AN/AN/ASTRRStar EquityN/AN/AN/AN/AN/AUAHCUnited American Healthcare$0.08567.38%N/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioAEMDAethlon MedicalN/A2.802.80LYRALyra TherapeuticsN/A3.643.64STRRStar Equity0.212.051.60UAHCUnited American HealthcareN/AN/AN/ACompare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipAEMDAethlon Medical1.99%LYRALyra Therapeutics95.62%STRRStar Equity3.84%UAHCUnited American HealthcareN/AInsider OwnershipCompanyInsider OwnershipAEMDAethlon Medical1.20%LYRALyra Therapeutics3.25%STRRStar Equity33.51%UAHCUnited American Healthcare14.31%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableAEMDAethlon Medical1016.06 million14.30 millionNo DataLYRALyra Therapeutics501.33 million62.39 millionOptionableSTRRStar Equity4603.21 million2.14 millionNot OptionableUAHCUnited American Healthcare31117.06 million100.31 millionNot OptionableUAHC, STRR, AEMD, and LYRA HeadlinesRecent News About These CompaniesUnited American Healthcare CorpShsMay 6, 2025 | markets.businessinsider.comUnited Healthcare data breach may have affected 190 million AmericansJanuary 27, 2025 | msn.comUnitedHealth CEO: American healthcare needs to be "less complex and less confusing'January 17, 2025 | msn.comUnitedHealth tops profit forecasts but medical costs linger for health care giantJanuary 16, 2025 | msn.comNews Wrap: United Healthcare CEO killed in brazen and targeted attack, New York police sayDecember 5, 2024 | pbs.orgHH Health System, United Healthcare reach agreementNovember 14, 2024 | elkvalleytimes.comUnited Healthcare reaches deal with Huntsville Hospital Health SystemNovember 14, 2024 | decaturdaily.comHow will a Trump presidency reshape US public health? A look at his plans.November 13, 2024 | usatoday.comDreamers eligible for health insurance through Covered California for first time this yearNovember 8, 2024 | thecalifornian.comDuke Health, UnitedHealthcare reach multi-year agreement, impacts over 172K patientsNovember 3, 2024 | msn.comAs ACA sign ups start, more Americans have health insurance than ever. Will it last?November 2, 2024 | msn.comUSA Health sets gala to celebrate health care workers’ impact on patientsOctober 31, 2024 | msn.comUnitedHealth Confirms Change Healthcare Data Breach Impacted 100 Million AmericansOctober 29, 2024 | cpomagazine.comMore than 100 million Americans had their health data exposed in a UnitedHealth hackOctober 26, 2024 | 9to5mac.comCyberattack at UnitedHealth subsidiary Change Healthcare affected 100M AmericansOctober 24, 2024 | startribune.comMore than 1,500 physicians call on Trump to release health care planOctober 18, 2024 | msn.comNew center aims to enhance public health preparedness in Utah and beyondOctober 11, 2024 | msn.comThe Plastic-Free Movement: Redefining Healthcare Disinfection for a Healthier PlanetOctober 9, 2024 | beckershospitalreview.comHealth Care Is on the Ballot AgainOctober 4, 2024 | theatlantic.comNew United Against the Flu toolkit urges vaccination before peak respiratory virus seasonSeptember 28, 2024 | aha.orgNew MarketBeat Followers Over TimeMedia Sentiment Over TimeUAHC, STRR, AEMD, and LYRA Company DescriptionsAethlon Medical NASDAQ:AEMD$0.36 -0.01 (-3.88%) Closing price 04:00 PM EasternExtended Trading$0.36 0.00 (-0.70%) As of 04:23 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Aethlon Medical, Inc., a medical therapeutic company, focuses on developing products to treat cancer and life-threatening infectious diseases in the United States. It develops Hemopurifier, a clinical-stage immunotherapeutic device that removes tumor-derived exosomes and life-threatening viruses and use in organ transplantation. The company was incorporated in 1999 and is based in San Diego, California.Lyra Therapeutics NASDAQ:LYRA$20.25 +15.32 (+310.75%) Closing price 04:00 PM EasternExtended Trading$18.81 -1.44 (-7.13%) As of 04:25 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Lyra Therapeutics, Inc., a clinical-stage biotechnology company, focuses on the development and commercialization of novel integrated drug and delivery solutions for the localized treatment of patients with ear, nose, and throat diseases. It's XTreo technology platform is designed to deliver medicines directly to the affected tissue for sustained periods with a single administration. The company's product candidates include LYR-210, an anti-inflammatory implantable drug matrix for the treatment of chronic rhinosinusitis (CRS), which is in Phase III clinical trial; and LYR-220 for CRS patients with and without nasal polyps. It has a collaboration agreement with LianBio Inflammatory Limited to develop and commercialize LYR-210 in mainland China, Hong Kong, Taiwan, Macau, South Korea, Singapore, and Thailand. The company was formerly known as 480 Biomedical, Inc. and changed its name to Lyra Therapeutics, Inc. in July 2018. Lyra Therapeutics, Inc. was incorporated in 2005 and is headquartered in Watertown, Massachusetts.Star Equity NASDAQ:STRR$2.62 +0.25 (+10.29%) Closing price 03:56 PM EasternExtended Trading$2.60 -0.02 (-0.84%) As of 04:25 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Star Equity Holdings, Inc. engages in the construction business in the United States and internationally. It operates through two segments: Construction, and Investments. It manufactures modular housing units, structural wall panels, permanent wood foundation systems, and other engineered wood products; supplies general contractors with building materials; holds real estate assets; and manages investments. The company was formerly known as Digirad Corporation and changed its name to Star Equity Holdings, Inc. in December 2020. Star Equity Holdings, Inc. was founded in 1985 and is headquartered in Old Greenwich, Connecticut.United American Healthcare OTCMKTS:UAHC$0.01 0.00 (0.00%) As of 05/30/2025United American Healthcare Corporation, through its subsidiaries, provides contract manufacturing services to the medical device industry. It also focuses on the production of natural rubber. The company was incorporated in 1983 and is based in Chicago, Illinois. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Zscaler Will Hit $360 Soon: Here’s the How and Why Buy The Dip in Okta, There’s Nothing Wrong With the Outlook Why SoundHound Could Be a Short Squeeze in the Making Why Schwab US Dividend Equity ETF Could Lead the Rotation Analysts Are Bullish on Marvell Stock Despite Amazon Deal Concern MarketBeat Week in Review – 05/26 - 05/30 Super Micro Computer Stock Finding Upside With NVIDIA's Blackwell 5 Reasons Costco Stock Will Hit New Highs This Year Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
